Next Article in Journal
Borrelia burgdorferi Sensu Lato in Questing and Engorged Ticks from Different Habitat Types in Southern Germany
Next Article in Special Issue
Single-Particle Characterization of SARS-CoV-2 Isoelectric Point and Comparison to Variants of Interest
Previous Article in Journal
Combination of rRT-PCR and Anti-Nucleocapsid/Anti-Spike Antibodies to Characterize Specimens with Very Low Viral SARs-CoV-2 Load: A Real-Life Experience
Previous Article in Special Issue
SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Epidemiological Significance of SARS-CoV-2 RNA Dynamic in Naso-Pharyngeal Swabs

Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise G. Caporale, 64100 Teramo, Italy
*
Author to whom correspondence should be addressed.
Microorganisms 2021, 9(6), 1264; https://doi.org/10.3390/microorganisms9061264
Submission received: 15 March 2021 / Revised: 23 April 2021 / Accepted: 7 June 2021 / Published: 10 June 2021
(This article belongs to the Special Issue SARS-CoV-2: Epidemiology and Pathogenesis)

Abstract

:
From 16 March to 15 December 2020, 132,357 naso-pharyngeal/oropharyngeal swabs were collected in the province of Teramo, Abruzzo Region, Italy, and tested for the presence of SARS-CoV-2 genomic RNA by a commercially available molecular assay. A total of 12,880 swabs resulted positive. For 8212 positive patients (4.150 women and 4.062 men) the median age was statistically different between women (median: 49.55 ± 23.9 of SD) and men (median: 48.35 ± 23.5 of SD) while no differences were found in the comparison between the cycle threshold for the N protein-encoding gene (CT N) median values and gender. Differences were observed in the CT N gene median values of swabs collected from March to September as well as in the pairwise comparison between September and October and between November and December. The CT N gene median values observed in specific periods characterizing the SARS-CoV-2 epidemic in 2020 were also compared with the incidence of COVID-19 cases; a strong inverse correlation was highlighted (Pearson correlation coefficient = −0.978). Our findings confirm the usefulness of the CT N values as an indirect detection parameter to monitor viral loads in the population.

1. Introduction

Since the emergence of SARS-CoV-2, almost 137,866,311 million confirmed cases of COVID-19 cases were reported globally [1] (up to 16 April 2021). In Italy, a total of 3809,193 million cases were confirmed (up to 16 April 2021), with 115,557 reported fatalities [2]. In order to support the national healthcare system, the Ministry of Health appointed the Istituti Zooprofilattici Sperimentali, public health veterinary institutes, to test for the presence of SARS-CoV-2 RNA, naso-pharyngeal/oropharyngeal swabs (NNS) collected from suspected human cases [3,4].
Accordingly, starting from 16 March 2020, swabs collected in the province of Teramo from Abruzzo, a central region of Italy, are regularly tested for the presence of SARS-CoV-2 RNA at the Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise (IZSAM).
In a preliminary study conducted in 2020 [4], the mean of cycle threshold for the N protein-encoding gene (CT N) values of the first swab from each positive patient tested from March to May 2020, was analyzed. In that study, we observed a trend of CT increasing from a median value of 27.9 (±6.0 CT median value of standard deviation) to 33.43 (±1.3 CT median value of standard deviation) between March and May 2020, suggesting that lockdown measures and the elimination of infection foci were able to reduce the overall viral loads [4]. In that period, a general lockdown was applied from March 9 until May 18 to the whole of Italy, allowing a significant reduction of virus transmission [5]. Furthermore, a statistically significant reduction of viral RNA loads was observed in the pairwise comparison between swabs collected in April and March 2020 [4]. In contrast, the absence of a statistically significant difference between May and April 2020 was probably due to the low number of positive samples detected in May [4]. In addition, no differences between CT N gene values were observed between males and females [4].
In the first three months of the epidemic, from March 2020 to the end of May, a total of 660 COVID-19 cases were confirmed in the province of Teramo [2]. Likewise, other Italian provinces, following a summer characterised by limited viral circulation, in September a rapid increasing of the epidemic curve was observed in the province of Teramo, which was overwhelmed by 7814 confirmed cases from October to December 2020 (Figure 1) [2].
Following the results of the preliminary study [4], further analysis of the CT N gene values of positive NNS swabs in patients tested from March to 15 December 2020 was performed in the province of Teramo in order to characterize the dynamic of SARS-CoV-2 RNA loads over a longer period of time and to verify the existence of links between CT N gene values and the epidemiological situation in the area.
The analysis was limited up to 15 December 2020 in order to avoid the interference with the B.1.1.7 lineage (VOC 202012/01) of SARS-CoV-2 positive cases detected for the first time in Abruzzo in that period [6].

2. Materials and Methods

The workflow for SARS-CoV-2 RNA detection in NNS swabs [3] has been previously described [3,4]. Briefly, the adopted molecular test (TaqMan 2019-nCoV (qPCR) assay kit v2 manufactured by Thermo Fisher (Thermo Fisher Scientific, Waltham, MA, USA) targets three different portions of SARS-CoV-2 genome namely the replicase, S and N protein-encoding genes. For practical reasons, out of the three values produced for each sample, for the downstream analysis, only the CT value associated with detection of the N protein-encoding gene was selected, since it is translated by the most abundant viral sub-genomic RNA [7].
Statistical analysis was performed using StatTools© (version 7.5.2 Palisade Corporation, Ithaca, NY, USA). A Mann–Whitney test was used to assess the statistical significance of differences among the CT N gene median values in NNS swabs collected from March to 15 December 2020 in the province of Teramo. Regression analysis was performed to verify the correlation between CT N gene median values and the incidence per 10,000 inhabitants of COVID-19 cases registered in three specific periods of the year: from March to April, from May to September and from October to December. These observation periods were selected because they characterize the epidemic curve observed in Italy: the first epidemic wave, the inter-epidemic period, and the second epidemic wave (Figure 1).
For each SARS-CoV-2 positive patient, the CT N gene value of the first positive swab was considered. The level of significance was set at a p-value of 0.05. In order to check the performance of the swabbing procedure, a real-time RT-PCR detecting the human ribonuclease P RNA component H1 (H1RNA) gene (RPPH1) on chromosome 14 was employed. This molecular test, included in the TaqMan 2019 nCoV Assay kit v1 by Thermo Fisher, was run with a total of 68 randomly selected SARS-CoV-2 RNA positive samples, within those included in this study. The swabs were selected, in equal number, based on the CT N value, including: CT N between 15 and 20 (CT N 15-20), CT N 20-25, CT N 25-30, and CT N 30-35. Furthermore, in order to assess the presence of a correlation between CT values and viral loads, log10 dilutions (seven replicates per dilution) of a SARS-CoV-2 isolate on cell cultures were processed by qPCR.

3. Results

From 16 March to 15 December 2020, IZSAM analyzed a total of 132,357 NNS collected in the province of Teramo and 12.880 NNS tested positive for SARS-CoV-2 RNA by qPCR. A total of 8212 positive patients was selected for further analysis, of which 4150 women and 4062 men (Table 1). The median age (years) was found statistically different (two-tailed Mann–Whitney test, p-value < 0.01) between women (median: 49.55 ± 23.9 of standard deviation) and men (median: 48.35 ± 23.5 of standard deviation). The CT N gene median values of the first positive swab between women and men were calculated and no statistically significant differences (two-tails Mann–Whitney test, p-value > 0.05) were found between women (median CT N: 29) and men (median CT N: 28).
CT values of the H1RNA gene, although reasonably analysed on a selected set of samples, clearly showed that the observed trends of SARS-CoV-2 CT N values are not related to the swabbing procedure as CT values of the H1RNA are constant (mean range 22.94 ± 2.794 SD to 23.29 ± 2.28 SD) in samples showing different loads of SARS-CoV-2 RNA (Figure 2A).
In order to assess the presence of a correlation between CT values and viral loads, log10 dilutions (seven replicates per dilution) of a SARS-CoV-2 isolate on cell cultures were processed. The results showed a linear correlation over seven order of magnitude (from 106 TCID50/mLto 100 TCID50/mL), with good intra-assay reproducibility at high, intermediate and low virus concentrations (Figure 2B).
Concerning the CT N values observed in the 8212 positive NNS, the mean and median values were 27.59 (±0.0983 CI 90%) and 29.00, respectively (Figure 3).
Furthermore, the CT N gene median values of the first positive swab for each individual were compared over time. In Table 2 the CT N gene values obtained during the months of observations and the number of swabs considered for each month are reported.
A statistically significant difference (two-tailed Mann-Whitney test) was observed among the CT N gene median values of swabs collected from March to September (Figure 4). In particular, the CT N gene median values observed in NNS collected in March 2020 were significantly lower than those collected in April (p-value < 0.0001), and the latter lower than those collected in May 2020 (p-value = 0.0033), thus suggesting progressively lower viral RNA loads from March to May 2020. A significant difference was also observed in the pairwise comparisons between September and October 2020 (p-value < 0.0001) and between November and December (p-value < 0.0001).
When the median values of CT N observed in the three main periods (March-April, May-September and October-December) characterising the SARS-CoV-2 epidemic in 2020 were compared with the incidence of COVID-19 cases (Table 3), a strong inverse correlation (Pearson correlation coefficient = −0.978) was observed.
In turn, no correlation between the CT N values and the age of the infected individuals was observed (Pearson correlation coefficient = −0.094).

4. Discussion

Although RNA loads in swabs can be influenced by several factors including the clinical status of the patients, timing and swabbing procedure, we analyzed the trend of the CT N values in NNS collected from March to mid-December 2020.
In this study, we assumed that albeit not a good predictor of viral load when looking at an individual patient’s test results [8], CT values may give an indirect indication of the general viral load in the exposure environment when the population level is considered. This kind of approach has been already and successfully applied in other studies [9,10], and CT values have been used not only as proxies for the amount of virus circulating in the population under study, but also to predict the trajectory of the epidemic [10]. Although measured by diagnostic molecular method detecting genomic RNA rather than only subgenomic RNAs or virus isolation, analysis of viral load may indeed provide critical data to implement effective control measures and disease modeling [11].
A pattern with progressive increasing of CT N gene values was observed from March to May, testifying to an overall reduction of viral RNA load in swabs. This pattern was inverted from September to October and then from November to December, with an increase of viral RNA load in swabs. It is also important to point out that this analysis was limited up to 15 December 2020. This was done to avoid the effect of B.1.1.7 lineage (VOC 202012/01) of SARS-CoV-2 firstly identified in mid-December 2020 in the Abruzzo region. Before that period, indeed, circulation of SARS-CoV-2 lineages belonging to variants of concern (e.g., B.1.1.7, P.1, and B.1.351) was not evidenced. Specifically, lineage B.1.177 (also known as Spanish variant) emerged in summer 2020 and quickly became the dominant lineage in this area during fall as a result of opening borders in summer 2020.
The first reduction of viral RNA load was observed from March to May, and it was concurrent with the effect of the general lockdown established all over Italy, with analogous repercussions also in the Teramo province (Figure 3).
Accordingly, the observed increase of RNA loads in NNS tested from September onward could be linked to the general relaxation of preventive measures during the summer as a result of the cessation of the general lockdown in Italy. This link is confirmed by the strong inverse correlation between + median values and COVID-19 incidence per 100,000 inhabitants, when the three main epidemiological periods, characterized by different rates of COVID-19 incidence, are considered. As highlighted in our previous work [4], one of the pitfalls of our findings is the lack of anamnestic data for each positive individual. Detailed information for each patient on the clinical status prior and after SARS-CoV-2 infection, disease severity, the date of symptom’s onset would be beneficial to better interpret the dynamic of RNA loads in NNS.
The data originated in this analysis are supported by the evidence that SARS-CoV-2 CT N value trends are not affected by the swabbing procedure as the human H1RNA gene, used as control, was constant across a selected set of SARS-CoV-2 positive samples showing a wide range of viral loads. Moreover, a correlation was evidenced between CT values and infectious virus in vitro, therefore high CT values (>30) are likely predictive of very limited amounts of infectious virus (≤101 TCID50/mL).
In conclusion, our findings strongly confirm the usefulness of using qPCR and related CT values as an indirect mean for monitoring the levels of viral load circulation in the population, although the emergence of new variants of the virus at the end of 2020, apparently more transmissible than the others, is posing new questions that should be addressed in the early future.

Author Contributions

Conceptualization, P.C. and A.L.; methodology, P.C., A.L. and M.L.D.; validation, P.C., M.L.D., L.A., F.C., A.D.G., V.Z., I.P., M.C., S.S. and A.L.; formal analysis, P.C., M.L.D., I.P., M.C. and S.S.; data curation, M.L.D., P.C., A.L.; writing—original draft preparation, P.C., and M.L.D., A.L.; writing—review and editing, M.L.D., P.C., A.L., L.A, F.C., A.D.G., V.Z., I.P., M.C., S.S. and G.S.; visualization, P.C, M.L.D. and A.L.; supervision, P.C.; project administration, G.M., N.D., D.M. and G.S.; funding acquisition, G.M., N.D., D.M. and A.L. All authors have read and agreed to the published version of the manuscript.

Funding

Funding were provided by the Italian Ministry of Health Ricerca Corrente 2020 MSRCTE0520 “PanCO: epidemiologia e patogenesi dei coronavirus umani ed animali” recipient Alessio Lorusso.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. 2020. Available online: https://covid19.who.int/ (accessed on 16 April 2021).
  2. Dipartimento della Protezione Civile. COVID-19 Italia—Monitoraggio della Situazione. 2020. Available online: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac82fe38d4138b1?width=600&height=600 (accessed on 17 February 2021).
  3. Lorusso, A.; Calistri, P.; Mercante, M.T.; Monaco, F.; Portanti, O.; Marcacci, M.; Cammà, C.; Rinaldi, A.; Mangone, I.; Di Pasquale, A.; et al. A “One-Health” approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health 2020, 10, 100135. [Google Scholar] [CrossRef] [PubMed]
  4. Danzetta, M.L.; Amato, L.; Cito, F.; Di Giuseppe, A.; Morelli, D.; Savini, G.; Mercante, M.T.; Lorusso, A.; Portanti, O.; Puglia, I.; et al. SARS-CoV-2 RNA Persistence in Naso-Pharyngeal Swabs. Microorganisms 2020, 8, 1124. [Google Scholar] [CrossRef] [PubMed]
  5. Gazzetta Ufficiale della Repubblica Italiana. Decreto del Presidente del Consiglio dei Ministri 9 Marzo 2020. 2020. Available online: https://www.gazzettaufficiale.it/eli/id/2020/03/09/20A01558/sg (accessed on 17 February 2021).
  6. Lorusso, A.; Calistri, P.; Savini, G.; Morelli, D.; Ambrosij, L.; Migliorati, G.; D’Alterio, N. Novel SARS-CoV-2 variants in Italy: The role of veterinary public health institutes. Viruses 2021, 13, 549. [Google Scholar] [CrossRef] [PubMed]
  7. Wu, H.Y.; Brian, D.A. Subgenomic messenger RNA amplification in coronaviruses. Proc. Natl. Acad. Sci. USA 2010, 107, 12257–12262. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Dahdouh, E.; Lázaro-Perona, F.; Romero-Gómez, M.P.; Mingorance, J.; García-Rodriguez, J. Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load. J. Infect. 2021, 82, 414–451. [Google Scholar] [CrossRef] [PubMed]
  9. Veronesi, L.; Colucci, M.E.; Pasquarella, C.; Caruso, L.; Mohieldin Mahgoub Ibrahim, M.; Zoni, R.; Pergreffi, M.; Arcuri, C.; Seidenari, C.; Viani, I.; et al. Virological surveillance of SARS-CoV-2 in an Italian northern area: Comparison of Real Time RT PCR cycle threshold (CT) values in three epidemic periods. Acta Bio-Med. Atenei Parm. 2020, 91, 19–21. [Google Scholar]
  10. Hay, J.A.; Kennedy-Shaffer, L.; Kanjilal, S.; Lennon, N.J.; Gabriel, S.B.; Lipsitch, M.; Mina, M.J. Estimating epidemiologic dynamics from cross-sectional viral load distributions. Science 2021. [Google Scholar] [CrossRef] [PubMed]
  11. Cevik, M.; Tate, M.; Lloyd, O.; Maraolo, A.E.; Schafers, J.; Ho, A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: A systematic review and meta-analysis. Lancet Microbe 2020, 2, e13–e22. [Google Scholar] [CrossRef]
Figure 1. Number of COVID-19 cases in Teramo province per day throughout 2020. The first period of national lockdown from 9 March 2020to 18 May 2020is highlighted. From October 2020 a system modulating the restrictions on mobility based on colours (increasing the levels of restriction from yellow to red) was established. and highlighted.
Figure 1. Number of COVID-19 cases in Teramo province per day throughout 2020. The first period of national lockdown from 9 March 2020to 18 May 2020is highlighted. From October 2020 a system modulating the restrictions on mobility based on colours (increasing the levels of restriction from yellow to red) was established. and highlighted.
Microorganisms 09 01264 g001
Figure 2. (A) Individuals CT N values of H1RNA of SARS-CoV-2 RNA positive samples (y axis). A number of 68 SARS-CoV-2 RNA positive samples were selected according to the CT N value and divided in four groups (x axis), (B) Mean with standard deviation of CT N values (y axis) of seven dilution of a SARS-CoV-2 isolate (x axis). Each dilution was tested in seven replicates. TCID, tissue culture infectious dose.
Figure 2. (A) Individuals CT N values of H1RNA of SARS-CoV-2 RNA positive samples (y axis). A number of 68 SARS-CoV-2 RNA positive samples were selected according to the CT N value and divided in four groups (x axis), (B) Mean with standard deviation of CT N values (y axis) of seven dilution of a SARS-CoV-2 isolate (x axis). Each dilution was tested in seven replicates. TCID, tissue culture infectious dose.
Microorganisms 09 01264 g002
Figure 3. Distribution of the CT N values in the 8212 positive NNS considered in the study.
Figure 3. Distribution of the CT N values in the 8212 positive NNS considered in the study.
Microorganisms 09 01264 g003
Figure 4. Mean values of CT N gene of the first positive swab per patient by month. Letters are denoting a statistically significant difference between values of CT N gene (p-value < 0.05).
Figure 4. Mean values of CT N gene of the first positive swab per patient by month. Letters are denoting a statistically significant difference between values of CT N gene (p-value < 0.05).
Microorganisms 09 01264 g004
Table 1. Number of individuals with a positive NNS in the province of Teramo included in the study (16 March–15 December 2020).
Table 1. Number of individuals with a positive NNS in the province of Teramo included in the study (16 March–15 December 2020).
Age
(Years)
WomenMenTotal
0–10209259468
11–20427463890
21–30397372769
31–40470489959
41–506145411155
51-607566811437
61–704755511026
71–80324363687
81–90278250528
91–10018885273
>10012820
Total415040628212
Table 2. Values of CT N gene of the first positive swab observed in each month.
Table 2. Values of CT N gene of the first positive swab observed in each month.
CT N values
MonthMeanMedianMinimumMaximumStandard
Deviation
5th percentile95th PercentileNumber of Swabs
March28.630.012.040.06.018.036.0316
April30.832.014.040.04.920.036.0202
May33.734.027.040.02.530.037.027
June35.736.034.037.01.534.037.03
July30.530.026.035.04.026.035.06
August29.631.018.036.05.119.036.059
September30.332.018.038.04.920.036.096
October27.428.011.039.05.518.035.01501
November27.629.08.038.05.118.035.04339
December26.728.08.038.05.716.037.01663
Table 3. Median values of CT N gene of the first positive swab, number of COVID-19 cases and incidence per 100,000 inhabitants observed in three periods of 2020 (March-April, May-September and October-December) in the province of Teramo.
Table 3. Median values of CT N gene of the first positive swab, number of COVID-19 cases and incidence per 100,000 inhabitants observed in three periods of 2020 (March-April, May-September and October-December) in the province of Teramo.
Median CT N ValueCOVID-19 CasesIncidence (×100,000)
March–April31641208.12
May–September32373121.10
October–December2878142537.01
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Calistri, P.; Danzetta, M.L.; Amato, L.; Cito, F.; Di Giuseppe, A.; Zenobio, V.; Morelli, D.; Puglia, I.; Caporale, M.; Scialabba, S.; et al. Epidemiological Significance of SARS-CoV-2 RNA Dynamic in Naso-Pharyngeal Swabs. Microorganisms 2021, 9, 1264. https://doi.org/10.3390/microorganisms9061264

AMA Style

Calistri P, Danzetta ML, Amato L, Cito F, Di Giuseppe A, Zenobio V, Morelli D, Puglia I, Caporale M, Scialabba S, et al. Epidemiological Significance of SARS-CoV-2 RNA Dynamic in Naso-Pharyngeal Swabs. Microorganisms. 2021; 9(6):1264. https://doi.org/10.3390/microorganisms9061264

Chicago/Turabian Style

Calistri, Paolo, Maria Luisa Danzetta, Laura Amato, Francesca Cito, Alessandra Di Giuseppe, Valentina Zenobio, Daniela Morelli, Ilaria Puglia, Marialuigia Caporale, Silvia Scialabba, and et al. 2021. "Epidemiological Significance of SARS-CoV-2 RNA Dynamic in Naso-Pharyngeal Swabs" Microorganisms 9, no. 6: 1264. https://doi.org/10.3390/microorganisms9061264

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop